CLINICAL OUTCOMES AND MOLECULAR CHARACTERIZATION FROM a PHASE II STUDY OF COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
暂无分享,去创建一个
G. Lenz | K. Ardeshna | B. Childs | P. Piraino | D. Heo | G. Beckmann | E. Hawkes | C. Peña | I. Gorbatchevsky | V. Buvaylo | J. H. Christensen | S. Lim | G. Chong | G. Salles | G. Verhoef | C. Haioun | V. Shi | S. Lippert | F. Hiemeyer